1. ScholarBank@NUS

Wee Joo Chng

rp04705

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
Main Affiliation
 
Faculty
 
Email
mdccwj@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Date Issued:  [2000 TO 2021]
Type:  Review
Date Issued:  [2010 TO 2019]

Results 1-20 of 23 (Search time: 0.014 seconds).

Issue DateTitleAuthor(s)
11-Nov-2019Comprehensive Analysis of ERK1/2 Substrates for Potential Combination ImmunotherapiesYang, Lei ; Zheng, Liangzhen; Chng, Wee Joo ; Ding, Jeak Ling 
22019EZH2 abnormalities in lymphoid malignancies: Underlying mechanisms and therapeutic implicationsLi, B. ; Chng, W.-J. 
32014Implications of heterogeneity in multiple myelomaDe Mel S.; Lim S.H.; Tung M.L.; Chng W.-J. 
4Feb-2014IMWG consensus on risk stratification in multiple myelomaChng, W.J. ; Dispenzieri, A.; Chim, C.-S.; Fonseca, R.; Goldschmidt, H.; Lentzsch, S.; Munshi, N.; Palumbo, A.; Miguel, J.S.; Sonneveld, P.; Cavo, M.; Usmani, S.; Durie, B.G.; Avet-Loiseau, H.
5Nov-2013Management of multiple myeloma in asia: Resource-stratified guidelinesTan, D.; Chng, W.J. ; Chou, T.; Nawarawong, W.; Hwang, S.-Y.; Chim, C.S.; Chen, W.; Durie, B.G.M.; Lee, J.H.
6Apr-2012Management of treatment-emergent peripheral neuropathy in multiple myelomaRichardson, P.G.; Delforge, M.; Beksac, M.; Wen, P.; Jongen, J.L.; Sezer, O.; Terpos, E.; Munshi, N.; Palumbo, A.; Rajkumar, S.V.; Harousseau, J.L.; Moreau, P.; Avet-Loiseau, H.; Lee, J.H.; Cavo, M.; Merlini, G.; Voorhees, P.; Chng, W.J. ; Mazumder, A.; Usmani, S.; Einsele, H.; Comenzo, R.; Orlowski, R.; Vesole, D.; Lahuerta, J.J.; Niesvizky, R.; Siegel, D.; Mateos, M.-V.; Dimopoulos, M.; Lonial, S.; Jagannath, S.; Bladé, J.; Miguel, J.S.; Morgan, G.; Anderson, K.C.; Durie, B.G.M.; Sonneveld, P.
72014MicroRNA: Important player in the pathobiology of multiple myelomaBi C.; Chng W.J. 
82011miRNA deregulation in multiple myelomaBi C.L.; Chng W.J. 
92014MMSET: Role and therapeutic opportunities in multiple myelomaXie Z.; Chng W.J. 
102-Apr-2019Molecular pathogenic pathways in extranodal NK/T cell lymphomade Mel, Sanjay; Hue, Susan Swee-Shan; Jeyasekharan, Anand D ; Chng, Wee-Joo ; Ng, Siok-Bian 
112014P53 abnormalities and potential therapeutic targeting in multiple myelomaTeoh P.J.; Chng W.J. 
122018Potential clinical application of genomics in multiple myelomaSoekojo, C.Y; de Mel, S; Ooi, M ; Yan, B; Chng, W.J 
132017Recent advances in acute promyelocytic leukaemiaNg, C.-H ; Chng, W.-J 
1414-Sep-2018RESISTANCE TO FLT3 INHIBITORS IN ACUTE MYELOID LEUKEMIA: MOLECULAR MECHANISMS AND RESENSITIZING STRATEGIESZhou, J ; CHNG WEE JOO 
151-Jan-2013Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancerZhou, J; Chng, WJ 
161-May-2019STAT3: A Promising Therapeutic Target in Multiple MyelomaChong, Phyllis SY ; Chng, Wee-Joo ; de Mel, Sanjay
172019Super-enhancers: Critical roles and therapeutic targets in hematologic malignanciesJia, Y.; Chng, W.-J. ; Zhou, J. 
182016The emerging roles of exosomes in leukemogeneisZhou, J ; Wang, S; Sun, K; Chng, W.-J 
192018The genomics and molecular biology of natural killer/T-cell lymphoma: Opportunities for translationde Mel S.; Soon G.S.-T.; Mok Y.; Chung T.-H. ; Jeyasekharan A.D. ; Chng W.-J. ; Ng S.-B. 
202018The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignanciesArora, L; Kumar, A.P ; Arfuso, F; Chng, W.J ; Sethi, G